Gateway 2012: Schenck AccuRate
Schenck AccuRate
746 E. Milwaukee Street
Whitewater, WI 53190
Phone: 800-558-0184
E-Mail: mktg@accuratefeeders.com
Website: www.accuratefeeders.com
Interphex Booth Number – 2443D
Visit booth 2443 to witness the collaboration between Schenck AccuRate, Sturtevant, Malvern and Powder Systems Ltd’s (PSL) recent release of a turnkey isolated milling suite. Named ARTMiS for Automated Real Time Milling System, the processing solution is housed inside PSL’s containment unit.
ARTMiS brings Sturtevant’s Micronizer® Jet Mill together with a Malvern Insitec particle size analyzer and the Schenck AccuRate PureFeed® AP-300 Screw Feeder for delivering a fully automated jet milling system. All three work in unison bringing accuracy in distribution, measurement, and feed rate for high value and/or highly potent materials.
In addition to the ARTMis system, Schenck AccuRate will also have its PureFeed DP-4 gravimetric feeder on display. The feeder can precisely handle feed rates from 20 to 2,000 grams.
Schenck AccuRate Company Description:
Schenck AccuRate is an ISO 9001 certified manufacturer of volumetric and gravimetric bulk solids feeders, vibratory feeders, weighfeeders, bulk bag frames, and control systems with expertise in handling dry materials for pharmaceutical processes. Schenck AccuRate and its parent, Schenck Process, offer worldwide sales, application engineering, and service support.
Company Products:
Designed to feed API’s, excipients, and other dry materials, the Schenck AccuRate PureFeed® feeder product line meets the highly sanitary requirements of pharmaceutical manufacturing. PureFeed® feeders feature 316L stainless steel, 32 microinch RA interior finishes, sanitary quick release clamps and easy disassembly for cleaning and maintenance. Feed rate ranges from .02 to 150 kg/hour.
Articles and Literature Links:
Manufacturer Designs Pharmaceutical-Grade Dry Material Feeder to Meet the Industry’s Needs
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
